Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma
Authors:
- David E. CohnDCDavid E. Cohn
- Emily M. WoesteEWEmily M. Woeste
- Stacey CacchioSCStacey Cacchio
- Vanna L. ZanagnoloVZVanna L. Zanagnolo
- Laura J. HavrileskyLHLaura J. Havrilesky
- Andrea MarianiAMAndrea Mariani
- Karl C. PodratzKPKarl C. Podratz
- Warner K. HuhWHWarner K. Huh
- Jenny M. WhitworthJWJenny M. Whitworth
- D Scott McMeekinDMD Scott McMeekin
- Matthew A. PowellMPMatthew A. Powell
- Emily BoydEBEmily Boyd
- 1 May 2007
- journal article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 109 (5) , 1062-1067
Abstract
To identify the surgical, pathologic, and therapeutic factors that influence outcome in patients with surgical stage II endometrial adenocarcinoma. All patients with comprehensively staged stage II endometrial adenocarcinoma were identified. Data regarding preoperative, surgical, pathologic, adjuvant therapy, and outcomes were collected. Factors were compared with the chi(2) test, and survival curves were generated and compared with the log rank test. Of 162 patients with surgical stage II endometrial cancer, the median age was 65 years, and the median body mass index was 31.2 kg/m(2). An extrafascial hysterectomy was performed in 75% of cases, whereas 25% of patients underwent radical hysterectomy. At least 10 nodes were recovered in more than 90% of cases. Stage IIA disease was present in 52% of cases, whereas stage IIB accounted for the remaining 48%. After staging, 48% of patients had adjuvant radiation therapy (16% with brachytherapy alone). The remainder received no adjuvant therapy. At a median follow-up of 26 months, 17% experienced disease recurrence. Five-year overall survival rate was 88% and disease-free survival rate was 81%. A significantly better 5-year disease-free survival rate was seen in patients undergoing radical hysterectomy compared with extrafascial hysterectomy (94% compared with 76%, P=.05). Adjuvant radiation did not lead to improved survival. In this large series of surgical stage II endometrial cancer cases, improved survival was noted relative to historical controls and in particular with radical compared with extrafascial hysterectomy.Keywords
This publication has 11 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: A patient care evaluation study from the American College of Surgeons National Cancer Data BaseGynecologic Oncology, 2005
- The long-term survival of women with surgical stage II endometrioid type endometrial cancerGynecologic Oncology, 2004
- Carcinoma of the corpus uteriInternational Journal of Gynecology & Obstetrics, 2003
- Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinomaObstetrics & Gynecology, 2002
- Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapyInternational Journal of Gynecological Cancer, 2001
- Role of Wide/Radical Hysterectomy and Pelvic Lymph Node Dissection in Endometrial Cancer with Cervical InvolvementGynecologic Oncology, 2001
- SEER Data, Corpus Uteri Cancer: Treatment Trends versus Survival for FIGO Stage II, 1988–1994Gynecologic Oncology, 1999
- Significance of true surgical pathologic staging: A Gynecologic Oncology Group studyAmerican Journal of Obstetrics and Gynecology, 1999
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995